Clinical Trial: A Study Comparing the Efficacy and Safety of HB1801 With Taxotere(R) in Advanced Breast Cancer

U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083505) titled 'A Study Comparing the Efficacy and Safety of HB1801 With Taxotere(R) in Advanced Breast Cancer' on July 15.

Brief Summary: This is a randomized, open-label, multicenter Phase II clinical trial evaluating the efficacy and safety of HB1801 compared with Taxotere(R) in patients with advanced breast cancer. A total of 60 subjects with advanced breast cancer are planned to be enrolled.The trial consists of three phases: screening period, open-label treatment period, and follow-up period. HB1801 is Docetaxel for injection (Albumin-bound).

Study Start Date: Aug. 15

Study Type: INTERVENTIONAL

Condition: Advanced Breast Cancer

Intervent...